References
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
- Nobel YR, Phipps M, Zucker J, et al. Gastrointestinal Symptoms and COVID-19-19: case-control study from the United States. Gastroenterology. 2020;12:S0016-5085(20)30490-X.
- Zhao S, Cao P, Chong MKC, et al. COVID-19 and gender-specific difference: analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020. Infect Control Hosp Epidemiol. 2020;41(6):750–751.
- Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–1130.
- Suleiman L, Négrier C, Boukerche H. Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol. 2013;88(3):637–654.
- Shioi A, Morioka T, Shoji T, et al. The inhibitory roles of vitamin K in progression of vascular calcification. Nutrients. 2020;12(2):583.
- Torii S, Ikari Y, Tanabe K, et al. Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcification. J Nutr Sci. 2016;5:e48.
- Dahlberg S, Schurgers L, Schött U, et al. Vitamin K deficiency in critical ill patients; a prospective observational study. J Crit Care. 2019;49:105–109.
- Dong R, Wang N, Yang Y, et al. Review on vitamin K deficiency and its biomarkers: focus on the novel application of PIVKA-II in clinical practice. Clin Lab. 2018;64(4):413–424.
- Viggiani V, Palombi S, Gennarini G, et al. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients. Scand J Gastroenterol. 2016;51(10):1257–1262.